Website News and Research

RSS

Childhood obesity: an interview with Professor Clodagh O’Gorman

Childhood obesity is harder to define than adult obesity. This is because any definition of obesity relies on measurements of both height and weight, and the calculation of body mass index (BMI) based on these measurements.

10 Dec 2012

JPND invites proposals from researchers to understand the underlying causes of neurodegenerative diseases

The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.

10 Dec 2012

Belmora introduces mobile cough control application

Belmora LLC, makers of the FLANAX line of Over-The-Counter (OTC) health care products, announced the launch of a mobile cough control application.

10 Dec 2012

Beth Israel Deaconess Medical Center introduces CeliacNow website

It's estimated that one in 100 people in the United States are living with celiac disease, but there are only a handful of celiac centers throughout the country. In response to a growing need for educational materials, clinicians at Beth Israel Deaconess Medical Center's Celiac Center have launched CeliacNow, a nutritional management website designed to maximize the health and wellbeing of people living with celiac disease and other gluten-related disorders.

10 Dec 2012

IQWiG investigates benefits of rilpivirine for HIV treatment

Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).

8 Dec 2012

IOM's Forum on Microbial Threats to take place from Dec.11-12

A two-day symposium will explore how much we have learned about new and re-emerging infectious diseases in the two decades since the Institute of Medicine issued a 1992 report pointing to major challenges in detecting and managing disease outbreaks.

6 Dec 2012

New method can generate stable human mesenchymal stem cells for bone engineering

Human mesenchymal stem cells (hMSCs) can develop into bone cells and are useful for tissue engineering and regeneration. However, when grown in the laboratory they quickly lose their ability to continue dividing and they die.

5 Dec 2012

Roundup: Building more Texas medical schools; Calif. mental health care for children

Recommendations in a new draft report on Texas undergraduate medical education caution against rushing to build any new medical schools, which may irk those that are pushing to do exactly that. The report was prepared by the staff of the Texas Higher Education Coordinating Board and posted on the agency's website on Monday in preparation for an upcoming meeting of their Task Force on Graduate Health Professions.

5 Dec 2012

Study explores osteoporosis racial differences in women

About 30 million women in the U.S. have osteoporosis, with low bone mass and deteriorating bone structure that increases their risk for fractures. Racial differences in the rates of detection and management of osteoporosis were explored in a study of African American and white women published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

5 Dec 2012

AliveCor receives FDA clearance on its mobile heart monitor

AliveCor, Inc. announced today at the start of the 4th annual mHealth Summit in Washington, D.C. that the company received FDA 510(k) clearance on its mobile Heart Monitor as well as CE Mark conformity. This clinical-quality, low-cost mobile ECG heart monitor, compatible with the iPhone® 4 and 4S, enables doctors to evaluate patient heart health easily, quickly and remotely.

3 Dec 2012

ADVENTRX Pharmaceuticals updates corporate website

ADVENTRX Pharmaceuticals, Inc. today announced the launch of its redesigned and updated corporate website,www.adventrx.com. The new website features clinician videos, patient resources, and important news pertaining to sickle cell disease and ADVENTRX's lead product candidate, ANX-188 (purified poloxamer 188).

3 Dec 2012

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

NeuroVive announces publication of the results of a Phase I clinical trial of lead product CicloMulsion in the scientific journal Clinical Drug Investigation. The paper highlights that the intravenous cyclosporine formulation CicloMulsion demonstrates bioequivalence and improved tolerability when compared with Sandimmune Injection.

3 Dec 2012

Article highlights Asian-American children’s variable vulnerability to obesity

Asian-American children have been at low risk for being overweight or obese compared to other racial and ethnic groups in the U.S., but that may be changing. Yet as rates of overweight and obesity rise, the risk appears to vary depending on the Asian country of origin, according to an article in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

30 Nov 2012

Modified vitamin D receptor may reduce risk of osteoporosis

Osteoporosis, or reduced bone mineral density that can increase the risk of fractures, may affect as many as 30% of women and 12% of men worldwide. One risk factor for osteoporosis is vitamin D deficiency.

30 Nov 2012

Cautious Patient Foundation, SIDM partner to raise awareness of diagnostic errors

The Society to Improve Diagnosis in Medicine (SIDM) and the Cautious Patient Foundation announced today a collaboration to help patients avoid diagnostic errors in their own care. Diagnostic error, defined as wrong, missed or delayed medical diagnosis, occurs in 10 to 15% of diagnostic encounters, is the largest contributor to medical malpractice claims, and is responsible for 40,000 - 80,000 deaths per year in the United States.

29 Nov 2012

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

During IVF treatment you will need to take certain drugs. For example, for IVF it will be Follicle Stimulating Hormones (FSH) which are used to stimulate the ovaries to produce a mature egg so that they can be fertilised externally and then put back into the womb.

29 Nov 2012

Rexahn intends to offer shares of common stock and warrants

Rexahn Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering.

29 Nov 2012

WHO releases inaugural issue of newsletter following developments of agency's reform

The WHO has released the inaugural issue of its newsletter Change@WHO, which will follow the developments of WHO reform, according to the agency's website, which notes "each issue will report on the three strands of programs and priority setting, governance and managerial reform."

28 Nov 2012

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Novo Nordisk announced today the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.

From Novo Nordisk 28 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

Website News and Research

Childhood obesity: an interview with Professor Clodagh O’Gorman

JPND invites proposals from researchers to understand the underlying causes of neurodegenerative diseases

Belmora introduces mobile cough control application

Beth Israel Deaconess Medical Center introduces CeliacNow website

IQWiG investigates benefits of rilpivirine for HIV treatment

IOM's Forum on Microbial Threats to take place from Dec.11-12

New method can generate stable human mesenchymal stem cells for bone engineering

Roundup: Building more Texas medical schools; Calif. mental health care for children

Study explores osteoporosis racial differences in women

AliveCor receives FDA clearance on its mobile heart monitor

ADVENTRX Pharmaceuticals updates corporate website

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

Article highlights Asian-American children’s variable vulnerability to obesity

Modified vitamin D receptor may reduce risk of osteoporosis

Cautious Patient Foundation, SIDM partner to raise awareness of diagnostic errors

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

Rexahn intends to offer shares of common stock and warrants

WHO releases inaugural issue of newsletter following developments of agency's reform

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News